Hypoxia-inducible factor (HIF) network: Insights from mathematical models

Cell Communication and Signaling

Volumn 11, Issue 1, 2013, Pages

  Cavadas, Miguel A S ^a   Nguyen, Lan K ^a   Cheong, Alex ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

FIH; HIF; Hypoxia; Mathematical model; PHD

Indexed keywords

ANKYRIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; HYPOXIA INDUCIBLE FACTOR ALPHA; HYPOXIA INDUCIBLE FACTOR BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; OXYGEN; PROTEIN BCL 2; PROTEIN BNIP3; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ARTHRITIS; CELL HYPOXIA; ENTERITIS; HUMAN; INFLAMMATION; MATHEMATICAL MODEL; MICROENVIRONMENT; NEOPLASM; PREDICTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84878706261     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-11-42     Document Type: Review

References (89)

1. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Semenza GL, Oncogene 2010 29 5 625 634 10.1038/onc.2009.441 19946328
2. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Semenza GL, Wang GL, Mol Cell Biol 1992 12 12 5447 5454 1448077
3. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Wang GL, Semenza GL, Proc Natl Acad Sci USA 1993 90 9 4304 4308 10.1073/pnas.90.9.4304 8387214
4. Proline hydroxylation and gene expression. Kaelin WG, Annu Rev Biochem 2005 74 115 128 10.1146/annurev.biochem.74.082803.133142 15952883
5. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Wang GL, Jiang BH, Rue EA, Semenza GL, Proc Natl Acad Sci USA 1995 92 12 5510 5514 10.1073/pnas.92.12.5510 7539918
6. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Keith B, Johnson RS, Simon MC, Nat Rev Canc 2012 12 1 9 22
7. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ, Nature 1999 399 6733 271 275 10.1038/20459 10353251
8. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, et al. Science 2001 292 5516 468 472 10.1126/science.1059796 11292861
9. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Ivanov S, Liao SY, Ivanova A, Danilkovitch-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, et al. Am J Pathol 2001 158 3 905 919 10.1016/S0002-9440(10)64038-2 11238039
10. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein. Yu F, White SB, Zhao Q, Lee FS, Canc Res 2001 61 10 4136 4142
11. Oxygen sensing by HIF hydroxylases. Schofield CJ, Ratcliffe PJ, Nat Rev Mol Cell Biol 2004 5 5 343 354 10.1038/nrm1366 15122348
12. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ, EMBO J 2001 20 18 5197 5206 10.1093/emboj/20.18.5197 11566883
13. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, et al. Cell 2001 107 1 43 54 10.1016/S0092-8674(01)00507-4 11595184
14. A conserved family of prolyl-4-hydroxylases that modify HIF. Bruick RK, McKnight SL, Science 2001 294 5545 1337 1340 10.1126/science.1066373 11598268
15. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein. Ebert BL, Bunn HF, Mol Cell Biol 1998 18 7 4089 4096 9632793
16. FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Mahon PC, Hirota K, Semenza GL, Genes Dev 2001 15 20 2675 2686 10.1101/gad.924501 11641274
17. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML, Science 2002 295 5556 858 861 10.1126/science.1068592 11823643
18. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. McNeill LA, Hewitson KS, Claridge TD, Seibel JF, Horsfall LE, Schofield CJ, Biochem J 2002 367 Pt 3 571 575 12215170
19. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Metzen E, Stiehl DP, Doege K, Marxsen JH, Hellwig-Burgel T, Jelkmann W, Biochem J 2005 387 Pt 3 711 717 15563275
20. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, Landazuri M, Del Peso L, Biochem J 2005 390 Pt 1 189 197 15823097
21. Ancient Atmospheres and the Evolution of Oxygen Sensing Via the Hypoxia-Inducible Factor in Metazoans. Taylor CT, McElwain JC, Physiology 2010 25 5 272 279 10.1152/physiol.00029.2010 20940432
22. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors. Xia Y, Choi H-K, Lee K, Eur J Med Chem 2012 49 24 40 22305612
23. Properties of switch-like bioregulatory networks studied by simulation of the hypoxia response control system. Kohn KW, Riss J, Aprelikova O, Weinstein JN, Pommier Y, Barrett JC, Mol Biol Cell 2004 15 7 3042 3052 10.1091/mbc.E03-12-0897 15107465
24. Mathematical Modeling of the HIF-1 Mediated Hypoxic Response in Tumours. Kooner P, Maini PK, Cavaghan DJ, Proceedings of the 2005 International Symposium on Mathematical and Computational Biology Rio de Janeiro: E-papers 2006 281 315
25. A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1 alpha. Qutub AA, Popel AS, J Cell Sci 2006 119 Pt 16 3467 3480 16899821
26. Pathway switching explains the sharp response characteristic of hypoxia response network. Yu Y, Wang G, Simha R, Peng W, Turano F, Zeng C, PLoS Comput Biol 2007 3 8 171 10.1371/journal.pcbi.0030171 17784783
27. Hypoxia-dependent sequestration of an oxygen sensor by a widespread structural motif can shape the hypoxic response-a predictive kinetic model. Schmierer B, Novak B, Schofield CJ, BMC Syst Biol 2010 4 139 10.1186/1752-0509-4-139 20955552
28. Three autocrine feedback loops determine HIF1 alpha expression in chronic hypoxia. Qutub AA, Popel AS, Biochim Biophys Acta 2007 1773 10 1511 1525 10.1016/j.bbamcr.2007.07.004 17720260
29. Gene regulation in response to graded hypoxia: the non-redundant roles of the oxygen sensors PHD and FIH in the HIF pathway. Dayan F, Monticelli M, Pouyssegur J, Pecou E, J Theor Biol 2009 259 2 304 316 10.1016/j.jtbi.2009.03. 009 19298827
30. An in silico model for HIF-alpha regulation and hypoxia response in tumor cells. Yucel MA, Kurnaz IA, Biotechnol Bioeng 2007 97 3 588 600 10.1002/bit.21247 17089387
31. A dynamic model of the hypoxia-inducible factor 1-alpha (HIF-1alpha) network. Nguyen LK, Cavadas MA, Scholz CC, Fitzpatrick SF, Bruning U, Cummins EP, Tambuwala MM, Manresa MC, Kholodenko BN, Taylor CT, et al. J Cell Sci 2013 126 Pt 6 1454 1463 23390316
32. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Jiang BH, Semenza GL, Bauer C, Marti HH, Am J Physiol 1996 271 4 Pt 1 1172 C1180 8897823
33. Mathematical modelling of the HIF-1 mediated hypoxic response in tumours. Kooner P, Maini P, Gavaghan D, Rio de Janeiro: E-papers Servicos Editoriais Ltda, Mondaini R, Dilao R, Proceedings of the 2005 International Symposium on Mathematical & Computational Biology BIOMAT 2005. 2006 261 316
34. HIF-1 alpha and p53: the ODD couple? Fels DR, Koumenis C, Trends Biochem Sci 2005 30 8 426 429 10.1016/j.tibs.2005.06.009 15996866
35. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. Huang LE, Arany Z, Livingston DM, Bunn HF, J Biol Chem 1996 271 50 32253 32259 10.1074/jbc.271.50. 32253 8943284
36. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Groulx I, Lee S, Mol Cell Biol 2002 22 15 5319 5336 10.1128/MCB.22.15.5319-5336.2002 12101228
37. Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro. Pan Y, Mansfield KD, Bertozzi CC, Rudenko V, Chan DA, Giaccia AJ, Simon MC, Mol Cell Biol 2007 27 3 912 925 10.1128/MCB.01223-06 17101781
38. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, Gottlieb E, Canc Cell 2005 7 1
39. Prolyl hydroxylases as regulators of cell metabolism. Boulahbel H, Duran RV, Gottlieb E, Biochem Soc Trans 2009 37 Pt 1 291 294 19143649
40. Accumulation of Krebs cycle intermediates and over-expression of HIF1 alpha in tumours which result from germline FH and SDH mutations. Pollard PJ, Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, et al. Hum Mol Genet 2005 14 15 2231 2239 10.1093/hmg/ddi227 15987702
41. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, Watson DG, Gottlieb E, Mol Cell Biol 2007 27 9 3282 3289 10.1128/MCB.01927-06 17325041
42. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates-Possible links between cell metabolism and stabilization of HIF. Koivunen P, Hirsila M, Remes AM, Hassinen IE, Kivirikko KI, Myllyharju J, J Biol Chem 2007 282 7 4524 4532 17182618
43. Activation of hypoxia-inducible factor-1; definition of regulatory domains within the alpha subunit. Pugh CW, O'Rourke JF, Nagao M, Gleadle JM, Ratcliffe PJ, J Biol Chem 1997 272 17 11205 11214 10.1074/jbc.272.17.11205 9111021
44. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. Jiang BH, Zheng JZ, Leung SW, Roe R, Semenza GL, J Biol Chem 1997 272 31 19253 19260 10.1074/jbc.272.31.19253 9235919
45. The hypoxia-inducible factor 2 alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo. Yan Q, Bartz S, Mao M, Li L, Kaelin WG Jr, Mol Cell Biol 2007 27 6 2092 2102 10.1128/MCB.01514-06 17220275
46. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Dayan F, Roux D, Brahimi-Horn MC, Pouyssegur J, Mazure NM, Canc Res 2006 66 7 3688 3698 10.1158/0008-5472.CAN-05-4564
47. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J, J Biol Chem 2004 279 11 9899 9904 14701857
48. Pharmacological characterization of 1-(5-chloro-6-(trifluoromethoxy)-1H- benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor. Barrett TD, Palomino HL, Brondstetter TI, Kanelakis KC, Wu X, Haug PV, Yan W, Young A, Hua H, Hart JC, et al. Mol Pharmacol 2011 79 6 910 920 10.1124/mol.110.070508 21372172
49. The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism. Zhang N, Fu Z, Linke S, Chicher J, Gorman JJ, Visk D, Haddad GG, Poellinger L, Peet DJ, Powell F, et al. Cell Metab 2010 11 5 364 378 10.1016/j.cmet.2010.03.001 20399150
50. MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A, Scholz CC, Simpson DA, Leonard MO, Tambuwala MM, Cummins EP, et al. Mol Cell Biol 2011 31 19 4087 4096 10.1128/MCB.01276-10 21807897
51. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels-Evidence for an autoregulatory oxygen-sensing system. Stiehl DP, Wirthner R, Koeditz J, Spielmann P, Camenisch G, Wenger RH, J Biol Chem 2006 281 33 23482 23491 10.1074/jbc.M601719200 16790428
52. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J, EMBO J 2003 22 16 4082 4090 10.1093/emboj/cdg392 12912907
53. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ, Gleadle JM, J Biol Chem 2004 279 37 38458 38465 10.1074/jbc.M406026200 15247232
54. Intracellular localisation of human HIF-1 alpha hydroxylases: implications for oxygen sensing. Metzen E, Berchner-Pfannschmidt U, Stengel P, Marxsen JH, Stolze I, Klinger M, Huang WQ, Wotzlaw C, Hellwig-Burgel T, Jelkmann W, et al. J Cell Sci 2003 116 Pt 7 1319 1326 12615973
55. HIF-1 and HIF-2 transcription factors-similar but not identical. Loboda A, Jozkowicz A, Dulak J, Mol Cells 2010 29 5 435 442 10.1007/s10059-010-0067-2 20396958
56. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J, Ratcliffe PJ, J Biol Chem 2009 284 25 16767 16775 10.1074/jbc.M901790200 19386601
57. Multistrip Western blotting to increase quantitative data output. Aksamitiene E, Hoek JB, Kholodenko B, Kiyatkin A, Electrophoresis 2007 28 18 3163 3173 10.1002/elps.200700002 17722184
58. Systems-level interactions between insulin-EGF networks amplify mitogenic signaling. Borisov N, Aksamitiene E, Kiyatkin A, Legewie S, Berkhout J, Maiwald T, Kaimachnikov NP, Timmer J, Hoek JB, Kholodenko BN, Mol Syst Biol 2009 5 256 19357636
59. Gaussia luciferase variant for high-throughput functional screening applications. Maguire CA, Deliolanis NC, Pike L, Niers JM, Tjon-Kon-Fat LA, Sena-Esteves M, Tannous BA, Anal Chem 2009 81 16 7102 7106 10.1021/ac901234r 19601604
60. NFkappaB and HIF display synergistic behaviour during hypoxic inflammation. Bruning U, Fitzpatrick SF, Frank T, Birtwistle M, Taylor CT, Cheong A, Cell Mol Life Sci 2012 69 8 1319 1329 10.1007/s00018-011-0876-2 22068612
61. Hypoxia and inflammation. Eltzschig HK, Carmeliet P, N Engl J Med 2011 364 7 656 665 10.1056/NEJMra0910283 21323543
62. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability. Knaup KX, Jozefowski K, Schmidt R, Bernhardt WM, Weidemann A, Juergensen JS, Warnecke C, Eckardt KU, Wiesener MS, Mol Canc Res 2009 7 1 88 98 10.1158/1541-7786.MCR-08-0288
63. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Wouters BG, Koritzinsky M, Nat Rev Canc 2008 8 11 851 864 10.1038/nrc2501
64. Inflammatory hypoxia: role of hypoxia-inducible factor. Karhausen J, Haase VH, Colgan SP, Cell Cycle 2005 4 2 256 258 15655360
65. Hypoxia and gastrointestinal disease. Taylor CT, Colgan SP, J Mol Med (Berl) 2007 85 12 1295 1300 10.1007/s00109-007-0277-z
66. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, Haase VH, J Clin Invest 2004 114 8 1098 1106 15489957
67. The vascular contribution in the pathogenesis of inflammatory bowel disease. Hatoum OA, Miura H, Binion DG, Am J Physiol Heart Circ Physiol 2003 285 5 1791 H1796 14561675
68. Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE, Lancet 1989 2 8671 1057 1062 2572794
69. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. Taylor CT, J Physiol 2008 586 Pt 17 4055 4059 18599532
70. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Bonello S, Zahringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, Gorlach A, Arterioscler Thromb Vasc Biol 2007 27 4 755 761 10.1161/01.ATV.0000258979.92828.bc 17272744
71. Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells. Belaiba RS, Bonello S, Zahringer C, Schmidt S, Hess J, Kietzmann T, Gorlach A, Mol Biol Cell 2007 18 12 4691 4697 10.1091/mbc.E07-04-0391 17898080
72. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. van Uden P, Kenneth NS, Rocha S, Biochem J 2008 412 3 477 484 10.1042/BJ20080476 18393939
73. Hypoxia-inducible factor (HIF) 1alpha accumulation and HIF target gene expression are impaired after induction of endotoxin tolerance. Frede S, Stockmann C, Winning S, Freitag P, Fandrey J, J Immunol 2009 182 10 6470 6476 10.4049/jimmunol.0802378 19414801
74. Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway. Kim J, Shao Y, Kim SY, Kim S, Song HK, Jeon JH, Suh HW, Chung JW, Yoon SR, Kim YS, et al. Mol Biol Cell 2008 19 2 433 444 18003981
75. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V, Johnson RS, Haddad GG, Karin M, Nature 2008 453 7196 807 811 10.1038/nature06905 18432192
76. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Koong AC, Chen EY, Giaccia AJ, Canc Res 1994 54 6 1425 1430
77. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, et al. Proc Natl Acad Sci USA 2006 103 48 18154 18159 10.1073/pnas.0602235103 17114296
78. Hydroxylase-dependent regulation of the NF-kappaB pathway. Scholz CC, Taylor CT, Biol Chem 2013 394 4 479 493 23362195
79. HIF-1alpha regulates epithelial inflammation by cell autonomous NFkappaB activation and paracrine stromal remodeling. Scortegagna M, Cataisson C, Martin RJ, Hicklin DJ, Schreiber RD, Yuspa SH, Arbeit JM, Blood 2008 111 7 3343 3354 10.1182/blood-2007-10-115758 18199827
80. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, Sobolewski A, Condliffe AM, Cowburn AS, Johnson N, et al. J Exp Med 2005 201 1 105 115 10.1084/jem.20040624 15630139
81. An intact canonical NF-kappaB pathway is required for inflammatory gene expression in response to hypoxia. Fitzpatrick SF, Tambuwala MM, Bruning U, Schaible B, Scholz CC, Byrne A, O'Connor A, Gallagher WM, Lenihan CR, Garvey JF, et al. J Immunol 2011 186 2 1091 1096 10.4049/jimmunol.1002256 21149600
82. Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha. Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, Frezza C, Bernard NJ, Kelly B, Foley NH, et al. Nature 2013 496 7444 238 242 10.1038/nature11986 23535595
83. Hallmarks of cancer: the next generation. Hanahan D, Weinberg RA, Cell 2011 144 5 646 674 10.1016/j.cell.2011.02.013 21376230
84. Hypoxia-a key regulatory factor in tumour growth. Harris AL, Nat Rev Canc 2002 2 1 38 47 10.1038/nrc704
85. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Fingar DC, Blenis J, Oncogene 2004 23 18 3151 3171 10.1038/sj.onc.1207542 15094765
86. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E, J Biol Chem 2002 277 31 27975 27981 10.1074/jbc.M204152200 12032158
87. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons JW, Semenza GL, Canc Res 2000 60 6 1541 1545
88. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, et al. Nat Med 2002 8 2 128 135 10.1038/nm0202-128 11821896
89. Towards philosophical foundations of Systems Biology: Introduction. Boogerd FC, Bruggeman FJ, Hofmeyr J-HS, Westerhoff HV, Systems Biology, Philosophical foundations Amsterdam: Elsevier, Boogerd FC, Bruggeman FJ, Hofmeyr J-HS, Westerhodd HV, 2007 3 19